Meera Sivendran, MD

Dermatology
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Radnor
Schedule onlineCall 610-902-2400
Headshot of Meera Sivendran, MD
Penn Medicine Provider

About me

  • Clinical Assistant Professor of Dermatology

My education and training

  • Medical School: Thomas Jefferson University Sidney Kimmel Medical College
  • Residency: Albert Einstein Medical Center
  • Residency: Geisinger Community Medical Center

Spoken languages

English
English

Reviews

Average Rating

852 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
October 2024
very professional, knowledgeable, and explains things thoroughly.
Anonymous
October 2024
excellent care delivered efficiently
Anonymous
October 2024
very careful and caring
Anonymous
October 2024
very pleased- knowledgeable with recommendations

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Sivendran is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Valdes Morales KL, Bornstein M, Hannah CE, Vazquez T, Rauck C, Rodriguez O, Elenitsas R, Ammazzalorso A, Sahrish I, Weikert BC, Baumrin, Sivendran M, Forrestel A, Rosenbach M Cytomegalovirus anogenital ulcers in an immunosuppressed patient , JAAD Case Rep, 28(65): 2025

Kaufman B, Sivendran M Perianal ulceration and verrucous papules , Cutis, 102(3): 2018,E22-E23

Sivendran S, Chang R, Pham L, Phelps RG, Harcharik ST, Hall LD, Bernardo SG, Moskalenko MM, Sivendran M, Fu Y, de Moll EH, Pan M, Moon JY, Arora S, Cohain A, DiFeo A, Ferringer TC, Tismenetsky M, Tsui CL, Friedlander PA, Parides MK, Banchereau J, Chaussabel D, Lebwohl MG, Wolchok JD, Bhardwaj N, Burakoff SJ, Oh WK, Palucka K, Merad M, Schadt EE, Saenger YM Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease , J Invest Dermatol, 134(8): 2014,2202-2211

Harcharik S, Bernardo S, Moskalenko M, Pan M, Sivendran M, Bell H, Hall LD, Castillo-Martín M, Fox K, Cordon-Cardo C, Chang R, Sivendran S, Phelps RG, Saenger Y Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma , J Am Acad Dermatol, 70(6): 2014,1036-44

Sivendran M, Mowad C Hyperpigmented patches on shins, palms, and soles , JAMA Dermatol, 149(2): 2013

Harchark S, Moskalenko M, Bernardo S, Sivendran M, Saenger Y, Sivendran S The role of targeted therapy on cancer treatment , The Journal of Lancaster General Hospital: 2012